TD Cowen began coverage on shares of Cullinan Oncology (NASDAQ:CGEM – Get Rating) in a research report sent to investors on Thursday, Briefing.com reports. The firm issued an outperform rating on the stock. Separately, HC Wainwright decreased their target price on Cullinan Oncology from $50.00 to $49.00 in a research report on Friday, May 12th. […]